Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
32.09
+0.38 (1.20%)
Dec 24, 2025, 1:00 PM EST - Market closed
Oruka Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$48.20
Upside
+50.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +133.72% | Dec 18, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +40.23% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $56 → $63 | Strong Buy | Maintains | $56 → $63 | +96.32% | Nov 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +86.97% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +24.65% | Oct 27, 2025 |
| Barclays | Barclays | Buy Initiates $48 | Buy | Initiates | $48 | +49.58% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +74.51% | Sep 29, 2025 |
| BTIG | BTIG | Strong Buy Maintains $44 → $56 | Strong Buy | Maintains | $44 → $56 | +74.51% | Sep 17, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +43.35% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +40.23% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +40.23% | Jul 23, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +24.65% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +40.23% | Feb 7, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $20 | Buy | Initiates | $20 | -37.68% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +40.23% | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +40.23% | Nov 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.